Chronic Myelogenous Leukemia, An Issue of Hematology/Oncology Clinics of North America, 1st Edition
Author :
Daniel DeAngelo
Dr. DeAngelo has assembled top experts to write state-of-the art reviews on the management of chronic myelogenous leukemia. Some of the articles that will be of most interest to readers include: Hurdles Toward a Cure for CML: The CML Stem Cell; The b
...view more
Dr. DeAngelo has assembled top experts to write state-of-the art reviews on the management of chronic myelogenous leukemia. Some of the articles that will be of most interest to readers include: Hurdles Toward a Cure for CML: The CML Stem Cell; The biology of CML progression: Who, what, where, and why?; Chronic Myeloid Leukemia – Mechanisms of Resistance and Treatment; BCR-ABL mutations in CML; Selection of therapy: Rational Decisions Based on Molecular Events; Chronic myelogenous leukemia: Role of stem cell transplant in the Imatinib era; Portal Vein Thrombosis and Budd Chiari Syndrome.
Dr. DeAngelo has assembled top experts to write state-of-the art reviews on the management of chronic myelogenous leukemia. Some of the articles that will be of most interest to readers include: Hurdles Toward a Cure for CML: The CML Stem Cell; The biology of CML progression: Who, what, where, and why?; Chronic Myeloid Leukemia – Mechanisms of Resistance and Treatment; BCR-ABL mutations in CML; Selection of therapy: Rational Decisions Based on Molecular Events; Chronic myelogenous leukemia: Role of stem cell transplant in the Imatinib era; Portal Vein Thrombosis and Budd Chiari Syndrome.
https://www.us.elsevierhealth.com/chronic-myelogenous-leukemia-an-issue-of-hematologyoncology-clinics-of-north-america-9781437725308.html6419Chronic Myelogenous Leukemia, An Issue of Hematology/Oncology Clinics of North Americahttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9781437725308.jpg79.1998.99USDInStock/Medicine/Hematology/Clinics/Clinics13743887255255041Dr. DeAngelo has assembled top experts to write state-of-the art reviews on the management of chronic myelogenous leukemia. Some of the articles that will be of most interest to readers include: Hurdles Toward a Cure for CML: The CML Stem Cell; The biology of CML progression: Who, what, where, and why?; Chronic Myeloid Leukemia – Mechanisms of Resistance and Treatment; BCR-ABL mutations in CML; Selection of therapy: Rational Decisions Based on Molecular Events; Chronic myelogenous leukemia: Role of stem cell transplant in the Imatinib era; Portal Vein Thrombosis and Budd Chiari Syndrome. Dr. DeAngelo has assembled top experts to write state-of-the art reviews on the management of chronic myelogenous leukemia. Some of the articles that will be of most interest to readers include: Hurdles Toward a Cure for CML: The CML Stem Cell; The biology of CML progression: Who, what, where, and why?; Chronic Myeloid Leukemia – Mechanisms of Resistance and Treatment; BCR-ABL mutations in CML; Selection of therapy: Rational Decisions Based on Molecular Events; Chronic myelogenous leukemia: Role of stem cell transplant in the Imatinib era; Portal Vein Thrombosis and Budd Chiari Syndrome.00add-to-cart97814377253082011 and earlierProfessionalBy Daniel DeAngelo, MD20111Book152w x 229hSaunders0Nov 28, 2011IN STOCK - This may take up to 5 business days to shipBy <STRONG>Daniel DeAngelo</STRONG>, MDClinicsClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
